Search by Drug Name or NDC

    NDC 45737-0242-16 BioGtuss 28; 388; 10 mg/5mL; mg/5mL; mg/5mL Details

    BioGtuss 28; 388; 10 mg/5mL; mg/5mL; mg/5mL

    BioGtuss is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Advanced Generic Corporation. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 45737-0242
    Product ID 45737-242_20a2b312-cedb-44e7-ae7b-c945c5000ab3
    Associated GPIs 43997303100933
    GCN Sequence Number 065716
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 388-28-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 27747
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name BioGtuss
    Proprietary Name Suffix NF
    Non-Proprietary Name Dextromethorphan, Guaifenesin, Phenylephrine
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 28; 388; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Advanced Generic Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 45737-0242-16 (45737024216)

    NDC Package Code 45737-242-16
    Billing NDC 45737024216
    Package 473 mL in 1 BOTTLE (45737-242-16)
    Marketing Start Date 2010-09-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 17414989-bc15-405d-b893-028250d5becf Details

    Revised: 12/2020